These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16159402

  • 1. Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice.
    Petersén A, Stewénius Y, Björkqvist M, Gisselsson D.
    BMC Cell Biol; 2005 Sep 13; 6():34. PubMed ID: 16159402
    [Abstract] [Full Text] [Related]

  • 2. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
    Crocker SF, Costain WJ, Robertson HA.
    Brain Res; 2006 May 09; 1088(1):176-86. PubMed ID: 16626669
    [Abstract] [Full Text] [Related]

  • 3. Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease.
    Josefsen K, Nielsen MD, Jørgensen KH, Bock T, Nørremølle A, Sørensen SA, Naver B, Hasholt L.
    J Neuroendocrinol; 2008 Feb 09; 20(2):165-72. PubMed ID: 18034868
    [Abstract] [Full Text] [Related]

  • 4. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
    Ribchester RR, Thomson D, Wood NI, Hinks T, Gillingwater TH, Wishart TM, Court FA, Morton AJ.
    Eur J Neurosci; 2004 Dec 09; 20(11):3092-114. PubMed ID: 15579164
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monitoring aggregate formation in organotypic slice cultures from transgenic mice.
    Smith DL, Bates GP.
    Methods Mol Biol; 2004 Dec 09; 277():161-71. PubMed ID: 15201455
    [Abstract] [Full Text] [Related]

  • 10. Gene expression in Huntington's disease skeletal muscle: a potential biomarker.
    Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH, Kooperberg C, Olson JM.
    Hum Mol Genet; 2005 Jul 01; 14(13):1863-76. PubMed ID: 15888475
    [Abstract] [Full Text] [Related]

  • 11. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model.
    Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, Wu YC, Sun CN, Chien CL, Lin YS, Wang SC, Tung YY, Chang C, Chern Y.
    J Neurochem; 2005 Apr 01; 93(2):310-20. PubMed ID: 15816854
    [Abstract] [Full Text] [Related]

  • 12. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
    André VM, Cepeda C, Venegas A, Gomez Y, Levine MS.
    J Neurophysiol; 2006 Apr 01; 95(4):2108-19. PubMed ID: 16381805
    [Abstract] [Full Text] [Related]

  • 13. Cerebellar lipid differences between R6/1 transgenic mice and humans with Huntington's disease.
    Denny CA, Desplats PA, Thomas EA, Seyfried TN.
    J Neurochem; 2010 Nov 01; 115(3):748-58. PubMed ID: 20731757
    [Abstract] [Full Text] [Related]

  • 14. Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice.
    Gil JM, Leist M, Popovic N, Brundin P, Petersén A.
    BMC Neurosci; 2004 May 10; 5():17. PubMed ID: 15134587
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment.
    Lazic SE, Grote HE, Blakemore C, Hannan AJ, van Dellen A, Phillips W, Barker RA.
    Eur J Neurosci; 2006 Apr 10; 23(7):1829-38. PubMed ID: 16623840
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.
    Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, Thompson LM, Zuccato C, Cattaneo E.
    Mol Cell Neurosci; 2008 Sep 10; 39(1):1-7. PubMed ID: 18571429
    [Abstract] [Full Text] [Related]

  • 20. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
    Glynn D, Reim K, Brose N, Morton AJ.
    Brain Res Bull; 2007 Apr 30; 72(2-3):108-20. PubMed ID: 17352934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.